http://www.youtube.com/watch?v=Ymnk5_QnnAgsums things up nicely , this one is tightly held by management and top holders, and will run hard if/when it does.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling